Skip to main content
. 2019 Dec 17;9:19226. doi: 10.1038/s41598-019-55429-8

Figure 2.

Figure 2

Assay of transcriptional activation for GSF. (A) Various forms of GSF, full-length (GSF1~557, positions 1–557), truncated transmembrane (GSF1–521, positions 1–521), truncated C terminal half (GSF1–160, positions 1–160) and truncated N terminal half (GSF161–521, positions 161–521), fused with Gal4 DNA-binding domain (GAL4BD) to form four different constructs (GAL4BD-GSF1~557, GAL4BD-GSF1~521, GAL4BD-GSF1~160 and GAL4BD-GSF161~521). GAL4BD-GAL4AD is a positive control, while GAL4BD only served as a negative control. (B) The six constructs from (A) were introduced into the yeast strain AH109 and grown on SD without tryptophan (W) or lacking tryptophan, histidine and adenine (WHA). (C) Quantification of the β-galactosidase activity for six different transformants in yeast from (B).